Cargando...

Clinical significance of plasmacytosis in the day+14 bone marrow of patients with acute myeloid leukaemia undergoing induction chemotherapy

BACKGROUND: The design of chemotherapy‐induction regimens for acute myeloid leukaemia (AML) is directed towards the early elimination of bone marrow (BM) leukaemic blast cells (LBCs). Patients with AML after induction show LBC reduction in a hypoplastic BM and also demonstrate a varying number of re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Al‐Shughair, Nada, Al‐Dawsari, Ghuzayel, Gyger, Martin, Mohamed, Gamal, Roberts, George
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2007
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1994521/
https://ncbi.nlm.nih.gov/pubmed/16731597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2005.032870
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!